← Eichor
Study identifier: NCT06733662 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

The Effect of Motivational Interviewing-Based Education on Treatment Adherence and Self-Care Agency in COPD Patients

Condition: Motivational Interviewing · COPD  ·  Sponsor: Kahramanmaraş İstiklal University

PhaseNA
Planned participants50
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

This randomized controlled trial will be conducted to evaluate the effect of education and motivational interviewing on treatment adherence and self-care power in COPD patients. Hypotheses of the Study; H1: Education and motivational interviewing in COPD patients increase treatment adherence in patients. H2: Education and motivational interviewing in COPD patients increase self-care power in patients. There will be two groups in the study: control and intervention groups. Before the intervention, pre-test data will be collected in the control and intervention groups. After the intervention, post-test data will be collected in both groups in line with the data collection forms.

This description comes directly from the study's public registry record.

Talk to the study team

Yasemin SAZAK  ·  541 447 49 44  ·  yasemin.sazak@istiklal.edu.tr

Always discuss trial participation with your own doctor first.

Locations (1)

Kahramanmaraş Istiklal UniverstyKahramanmaraş, Turkey (Türkiye)Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06733662